(HealthDay News) — Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients undergoing abdominal panniculectomy, according to a study published in ...

The FDA issued a safety alert for avacopan following reports of serious drug-induced liver injury and vanishing bile duct syndrome in adult patients.

Discontinuing β-blockers after one year or longer is noninferior for all-cause death, recurrent MI, or hospitalization for heart failure.

Iptacopan is a complement factor B inhibitor targeting the overactive alternative complement pathway in IgA nephropathy.

The investigators assessed temporal changes in patterns of induction therapy, and evaluated short-term renal and survival outcomes, as well as safety outcomes, prior to and following the introduction ...

The researchers found that weight loss was higher in association with greater dietary repetition (both metrics) and more daily calorie stability. Participants with higher weekend-weekday deviations ...

The phase 2 ASSIST trial showed that atrasentan has an additional antiproteinuric effect -- approximately 25% -- over 12 weeks in patients with earlier-stage IgA nephropathy already receiving ...

Serum levels of B vitamins don't adequately reflect nutritional state for patients with chronic kidney disease (CKD).

Systemic lupus erythematosus (SLE) phenotype may be more informative than generic cardiovascular risk stratification.

In children undergoing ESWL, adjunctive α1-blocker therapy enhances the stone-free rate and reduces the stone expulsion time. Children with urolithiasis who receive adjunctive α1-blocker therapy after ...

Each 10 percent increase in percentage of total food weight from ultraprocessed food linked to 4 percent higher BPH risk.

In subgroup analyses, no associations seen for oral contraceptive pills, intrauterine devices, medroxyprogesterone acetate injection.